Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes.

Michael BöttcherHans-Dirk DüngenVasile CorceaFrank DonathRainard FuhrPim GalGerd MikusDietmar TrenkMartin CoenenPhilippe Vieira PiresClaudia MaschkeAntonios Othon AliprantisNina BescheCorina Becker

Published in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2023)

ClinicalTrials.gov number, NCT03504982.

Keyphrases

placebo controlled
double blind
clinical trial
study protocol
coronary artery disease
coronary artery
phase iii
phase ii
randomized controlled trial
heart failure
squamous cell carcinoma
phase ii study
left ventricular
locally advanced